Latest News
|
1 February 2013
0 Likes 
The US Food and Drug Administration (FDA) has received approval from a federal judge for a consent decree of permanent injunction between it and Ben Venue Laboratories, a manufacturing facility long
Read More...
Latest News
|
24 October 2012
0 Likes
Greece is one of many countries, including the US and Canada, currently experiencing shortages of numerous drugs. But unlike other countries, Greece, which is in the midst of an economic crisis, has
Read More...
Latest News
|
18 October 2012
0 Likes
The US Food and Drug Administration (FDA) plans to continue to allow a substitute for the anti-cancer drug Doxil, manufactured by Johnson & Johnson subsidiary Ben Venue Laboratories, into the country
Read More...
Latest News
|
18 October 2012
1 Likes
Chronic regulatory lapses at manufacturing facilities are exacerbating drug shortages and patient safety issues, claims a new report published in The New York Times.The report chronicles the huge
Read More...
Latest News
|
9 October 2012
0 Likes
A long-running drug shortage involving Johnson & Johnson's anti-cancer drug Doxil (doxorubicin) may be on the verge of easing after the company applied to both the US Food and Drug Administration
Read More...
Latest News
|
10 September 2012
0 Likes
In at least one respect, 2011 was not a banner year for the US Food and Drug Administration (FDA): drug shortages. While the agency managed to approve 35 new drugs, 267 were in short supply at one
Read More...
Latest News
Regulatory Update
|
4 September 2012
0 Likes
Editor's note: the majority of Brazilian regulatory authorities ended their strike on Monday, 3 September 2012 according to Reuters. Approximately 10% of workers remain on strike.The Brazilian press
Read More...
Latest News
|
21 August 2012
0 Likes
Pharmacists and patients in Canada are experiencing frequent drug shortages as the result of numerous and complex factors, leading the Canadian Medical Association Journal (CMAJ) to call for a
Read More...
Latest News
|
4 June 2012
0 Likes
The US Food and Drug Administration (FDA) is proposing to extend an information program known as the Emergency Shortages Data Collection System (ESDCS) through which it collects data on medical device
Read More...
Latest News
|
30 May 2012
0 Likes
The US Food and Drug Administration (FDA) warned consumers on 29 May of counterfeit copies of Teva Pharmaceutical Industries’ attention deficit hyperactive disorder (ADHD) drug Adderall, saying some
Read More...